A mixed method study assessing the adverse events occurring post-covid-19 vaccination among healthcare professionals both quantitatively and qualitatively
Latest Information Update: 18 Nov 2021
At a glance
- Drugs AZD 1222 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 18 Nov 2021 New trial record
- 01 Nov 2021 Results published in the International Immunopharmacology